Skip to main content
. 2010 Aug 26;15(9):935–943. doi: 10.1634/theoncologist.2009-0279

Figure 2.

Figure 2.

Comparing patient-reported outcomes between epoetin alfa treatment and best standard care. (A): Percent change in mean FACT-An subscale scores between baseline and week 12 (mITT population). (B): Percent change in mean CLAS score between baseline and week 12 (mITT population).

Abbreviations: CLAS, Cancer Linear Analog Scale; FACT-An, Functional Assessment of Cancer Therapy–Anemia; mITT, modified intention-to-treat.